Umbilical cord MSC therapy in Istanbul, from Wharton's jelly
The cells our clinic works with, why this source was chosen, what is checked before a dose reaches you, and how our medical team builds the treatment around your case.
Umbilical Cord MSC Therapy at Our Istanbul Clinic
This page explains what umbilical cord msc therapy is, how our medical team plans it, and what treatment in Istanbul involves. It is general information rather than a treatment plan: suitability is confirmed only after our team has reviewed your diagnosis, your records, the alternatives open to you, and the goals you want treatment to support.
At a glance
Umbilical Cord MSC Therapy at a glance
- Biological material
- Mesenchymal stromal cells isolated from donated umbilical cord tissue after delivery.
- How it is given
- Depends on your plan. Donor consent, screening, traceability, processing, storage and release testing apply whichever route is used.
- Where it sits today
- Many uses in autoimmune, neurological and degenerative conditions remain investigational, and we say so when that applies to your case.
- Who it may suit
- That is decided case by case. This page explains the treatment; suitability is confirmed only after our medical team has reviewed your records.
From cord donation to the dose you receive
Umbilical cord tissue is a well-studied source of mesenchymal stromal cells. The visual follows the material from donation and screening through culture and testing to the dose given in clinic.

Clinical context

Microscopic research viewIllustrative detail
- Donation and screening
- Consent, maternal and donor history, infectious-disease screening, collection, and chain of custody open the record.
- Processing and release
- Isolation, expansion, identity markers, sterility, viability, and dose are all checked against defined criteria before release.
- Traceable to you
- The batch, transport, storage, preparation, and administration stay linked to your file, along with the plan if a reaction occurs.
What Is Umbilical Cord MSC Therapy?
This treatment uses mesenchymal stromal cells from Wharton's jelly, the gelatinous connective tissue inside the umbilical cord that cushions its blood vessels. The cord is donated after a healthy birth, the mother consents in writing, and she is screened for infectious disease before anything is used. It is tissue that would otherwise be discarded, nothing is done to mother or baby to obtain it, and none of the ethical questions attached to embryonic sources arise. Patients searching for umbilical cord stem cells, for UC-MSC therapy or for Wharton's jelly stem cells are looking at this same material.
Our clinic works with this source deliberately, and the reasons are worth knowing. Wharton's jelly is a young perinatal tissue rather than an adult one, unlike cells taken from bone marrow or fat. The cells expand readily in culture, so a whole batch can be grown, characterised and release-tested before any of it reaches a patient. They carry a low-immunogenicity profile, which is why this source is studied for use between unrelated people rather than requiring cells harvested from you. And they have a strong secretory profile: these cells are studied for the signalling molecules they release, which is the mechanism most mesenchymal stromal cell research now centres on.
Every batch arrives with its own record: donor consent and screening, the manufacturing facility and its GMP-aligned processes, identity testing, sterility and endotoxin results, viable cell count, storage conditions and the transport record, gathered into a certificate of analysis. Our team goes through that certificate with you, a physician administers the dose, and the route follows the goal your plan sets rather than habit. Send your medical records for a case review and we will tell you whether this treatment fits your diagnosis and what the plan would contain.
How Umbilical Cord MSC Therapy Works
These are the biological ideas umbilical cord msc therapy is built on. How much of it applies to you depends on your diagnosis, the goals set during your case review, the route of administration and the rest of your clinical picture, which is what our medical team works through with you.
- These cells work by releasing biological signals that influence the cells around them, a process called paracrine signalling, rather than by travelling to an area of damage and becoming replacement tissue - which is not what the research describes
- They release cytokines, the proteins cells use to speak to the immune system, and this is where research into an overactive inflammatory response is concentrated
- Shifting how the immune system behaves rather than suppressing it is called immunomodulation, and it is the most studied property of these cells
- Growth factors they release are studied for the support they may give to the repair processes tissue already runs for itself
- Signals that encourage new small blood vessels, called angiogenic signalling, matter because blood supply shapes how tissue recovers
- Viability, cell count, passage number, storage and dose all shape what actually reaches you, which is why the batch record is part of your treatment plan
Stem cells and exosomes are different.
One is a living cell. The other is a cell-derived messenger. The difference shapes how each is sourced, how it is given, and which one our medical team may propose for your case.

- 01 / SOURCE
Living source cells
Mesenchymal stromal cells are living cells. Their behavior depends on source, handling, dose, and biological context.
- 02 / SIGNAL
Released signals
Cells release soluble factors and extracellular vesicles. Exosomes are one subset of these small vesicles.
- 03 / RESPONSE
Local cell response
Nearby cells may respond to those signals. That biological rationale is where treatment planning starts, not a promise of a result.
Sourcing and handling
Wharton’s jelly: where our cells come from, and why.
We work with mesenchymal stromal cells from Wharton’s jelly, the gelatinous tissue inside the umbilical cord. It is collected after a healthy birth, with written maternal consent, from tissue that would otherwise be discarded. No harm comes to mother or baby, and none of the ethical questions attached to embryonic sources apply here.
It is also a young, perinatal source rather than adult bone marrow or fat, and it has a low-immunogenicity profile — which is why these cells are studied for use between unrelated people rather than requiring a patient’s own. They expand readily in culture, so a batch can be fully characterised and release-tested before any of it reaches a patient, and they are studied above all for what they secrete: the signalling molecules at the centre of most current MSC research. Before treatment begins, our team takes you through the origin of the material in your plan, how it was handled and what was checked.

01 / ORIGIN
Donation and consent
The cord is donated after a healthy birth, with written maternal consent and documented donor screening.
02 / ISOLATION
Controlled processing
The cells are isolated from the tissue and expanded in culture, and our team explains where that work is done.
03 / VERIFICATION
Release testing
Identity, sterility, viability and contamination checks are recorded, and the results follow the batch.
04 / CUSTODY
Clinical handling
Storage, transport, preparation and traceability are documented for the material used in your plan.
Your case review
How Our Medical Team Assesses Suitability
The purpose of the review is clarity. Your diagnosis, medical history, reports, imaging, current medication and the goals that matter to you give our team the context to plan treatment, or to tell you that this route is not right for your case.
- Autoimmune and inflammatory conditions that are under specialist care and documented in recent reports
- Neurological diagnoses where a therapeutic goal can be described clearly enough to be reviewed later
- Joint, tendon and soft-tissue conditions supported by recent imaging
- Patients who would rather receive a characterised donor batch than undergo a procedure to harvest their own cells
- Suitability is confirmed after our team assesses active infection, cancer history, pregnancy, immune status, anticoagulation and current medication
Setting Realistic Goals for Your Treatment
Before treatment we agree on what we are aiming for: measures that fit your condition, a realistic period over which to review them, and what would count as no meaningful change. Goals are not predictions. Responses vary between patients and no clinical outcome can be guaranteed.
- The goal is written into the plan before treatment, in the terms that matter to you, and is reviewed against the baseline we record beforehand
- Laboratory findings about signalling explain why these cells are studied; they are not a forecast of how one patient will respond
- Condition-specific follow-up continues alongside your established care and any rehabilitation already in place
- Repeat treatment is considered only where the review supports it, not scheduled in advance
- Regenerative medicine is planned individually: responses vary between patients, no clinical outcome can be guaranteed, suitability is confirmed only after medical review, and treatment is planned alongside your existing care
Your next step
Find out whether umbilical cord msc therapy may suit your case
If umbilical cord msc therapy looks relevant to your diagnosis, the next step is a review of your own records by our medical team. If it does not, we can explain which of the other routes we plan may fit better.
Suitability is confirmed only after our medical team has reviewed your records, and treatment is planned alongside the care you already receive.
From Your Records to an Agreed Treatment Plan
How our team moves from your first records review to a plan you can act on: evidence, risk, practical detail and follow-up, settled before you travel.
Send your medical records
Recent reports, imaging, your current medication, and what you hope treatment will help with. It lets our medical team make the review specific to you.
Start your case reviewSend your medical records
Our patient coordination team starts with your confirmed diagnosis, recent reports and imaging, current medications, previous procedures, and the outcomes that matter most to you.
Medical case review
Our medical team reads the file and decides whether this pathway is relevant to your case, which route would suit it, and where your existing care should stay in the lead.
Read your written treatment plan
You receive the biological material proposed and its documentation, the preparation and dose, the route, the schedule, the monitoring, the risks, the alternatives, and an itemized cost, in writing.
Plan your treatment in Istanbul
We confirm appointment timing, how long to stay, airport transfers, accommodation, mobility needs, medication instructions and your local contact before you book travel.
Stay in contact after you go home
Before treatment we agree what will be measured, when it will be reviewed, who answers your questions once you are home, and how your own clinician is kept informed.
Umbilical Cord MSC Therapy - Frequently Asked Questions
What is Wharton's jelly?
The gelatinous connective tissue inside the umbilical cord, the soft material that surrounds and cushions the cord's blood vessels. It is an unusually rich source of mesenchymal stromal cells, and those cells are what our laboratory isolates and grows. Wharton's jelly is simply the precise name for the material often described more loosely as umbilical cord tissue.
Why Wharton's jelly rather than my own cells?
It is a young perinatal tissue rather than an adult one, it is collected without any procedure on you, and the cells expand readily in culture, so a batch can be characterised and release-tested before a dose is ever prepared. Their low-immunogenicity profile is the reason this source is studied for use between unrelated people. Our medical team explains why it suits your plan.
Are Wharton's jelly stem cells the same as embryonic stem cells?
No, and the two are not related. These are mesenchymal stromal cells taken from the cord after a healthy birth has already happened, with written maternal consent, from tissue that would otherwise be discarded. None of the ethical questions attached to embryonic sources arise here, and the donation is documented for every batch.
What else is this treatment called?
Umbilical cord stem cells, UC-MSC therapy, and Wharton jelly MSC treatment written without the apostrophe are all names for the same material. What actually differs between one plan and another is the preparation, the dose and the route, which is what your written plan sets out.
Do I need to be a tissue match?
Routine tissue matching is not generally used for donor-derived MSC products, and the low-immunogenicity profile of this cell type is a large part of why. That does not make the cells invisible to your immune system, so the treating physician reviews compatibility, infusion and immune considerations for your case.
Where does the tissue come from, and is the donation ethical?
From mothers who consent in writing to donate the cord after a healthy birth, following eligibility and infectious-disease screening. No harm comes to mother or baby, the cord would otherwise be discarded, and chain of custody and de-identification are documented. You can ask to see that part of the record along with the certificate of analysis.
What quality documentation do I receive?
The batch certificate of analysis: identity testing, sterility and endotoxin results, viable cell count, passage, storage conditions and release criteria, alongside the donor screening and traceability record. Our team goes through it with you before the dose is given.
Are there side effects?
Possible effects depend on the route and the individual, and include infusion or injection reactions, temporary fever or fatigue, and procedure-related risks such as infection at the site. Your plan lists what applies to you, what we monitor for, and who to contact if something concerns you afterwards.
How do I find out whether I may be suitable for treatment in Istanbul?
Send your confirmed diagnosis, recent reports and imaging, current medications and medical history to our patient coordination team. Our medical team reviews suitability case by case and tells you in writing whether this pathway fits your situation, and what it would involve.
How long do international patients stay in Istanbul?
It depends on the plan our medical team proposes: the procedure, the route, the monitoring, your mobility and the follow-up all affect it. Your written schedule states the number of days before you book flights or accommodation.
Is this treatment safe?
No medical treatment is free of risk, and we are direct about that. Our team reduces the risks that can be reduced: screened donor material, batch testing before release, administration by a physician in a clinical setting, monitoring during and after the procedure, and a written account of the side effects and contraindications that apply to your plan.
What results can I expect?
Your plan states a therapeutic goal and how it will be measured, not a promised outcome. Our medical team explains what change would be meaningful in your case, when it will be reviewed, and what we would do next if that review shows no benefit.
How much does treatment cost in Istanbul?
Pricing is case-specific: the material, the preparation and dose, the route, the number of sessions, the monitoring and any travel services all affect it. Our patient coordination team sends an itemized written estimate so you can see what each part of the plan costs before you commit.
What does the international patient program include?
Your estimate lists the medical review, tests, the procedure itself, monitoring, medications, airport transfers, accommodation arrangements, written discharge information and follow-up as separate lines, so you can see what is included and what is not.
How this guide is maintained
How This Guide Is Written and Reviewed
Editorial reviewHow this guide is reviewed
This guide carries a last-reviewed date. Review asks whether the way we describe umbilical cord msc therapy and the research behind it still matches the published literature.
Where the evidence is limited, mixed or still emerging, the page says so rather than settling the question in the treatment's favour.
SourcingWhat we count as a source
Peer-reviewed human studies, trial registry entries and regulatory guidance. Laboratory and animal work is labelled as preclinical, and individual case reports are described as case reports.
Marketing material, including our own, is not treated as evidence.
Your treatment planWhat our medical team sets out
Before you agree to anything, our team can set out in writing the material proposed for your plan, how it is sourced, processed and release-tested, the route of administration, the monitoring plan, the full cost with exclusions, and who is clinically responsible for your care.
If any part of that is unclear, ask us. Your plan should make sense to you before you travel.

Evening on the Bosphorus, with a ferry and the bridge beyond. It shows the city you would travel to, not our clinic, your accommodation, or a service included in a plan.
Cell source documentation comes before travel
Donor screening, tissue source, processing, cell identity, release tests, dose, administration route, and monitoring are documented before your Istanbul visit is arranged.
Keep researching
Related Treatments and Conditions for Umbilical Cord MSC Therapy
Treatment
Intravenous Stem Cell Therapy
How an infusion session runs, how you are monitored, and when our team proposes this route.
Learn more→
Treatment
Stem Cell Therapy
Our MSC-based treatment in Istanbul: the cells we use, how a plan is built, and what treatment involves.
Learn more→
Treatment
Intrathecal Stem Cell Therapy
Delivery into the spinal canal: how the procedure is performed, how patients are monitored, and its risks.
Learn more→
Treatment
Exosome Therapy
Vesicle-based preparations, how they differ from a cell therapy, and where the research currently stands.
Learn more→
Condition
Multiple Sclerosis (MS)
How regenerative medicine is planned for Multiple Sclerosis (MS) at our Istanbul clinic.
Learn more→
Condition
Rheumatoid Arthritis
How regenerative medicine is planned for Rheumatoid Arthritis at our Istanbul clinic.
Learn more→
Condition
Lupus (Systemic Lupus Erythematosus)
How regenerative medicine is planned for Lupus (Systemic Lupus Erythematosus) at our Istanbul clinic.
Learn more→
Condition
Osteoarthritis
How regenerative medicine is planned for Osteoarthritis at our Istanbul clinic.
Learn more→
Condition
Premature Ovarian Failure (POF)
How regenerative medicine is planned for Premature Ovarian Failure (POF) at our Istanbul clinic.
Learn more→
More from our clinic
Planning your umbilical cord msc therapy in Istanbul
The practical side of treatment at our clinic: what the research shows, who may be suitable, what a plan costs, and how your stay in Istanbul and your follow-up are arranged.
Cost, Outcomes & Istanbul
- Visit our Istanbul clinicWhere we are, how patients reach us, and what to arrange before you travel.
- Understand treatment pricingWhat shapes a quote, and what an itemized estimate from our clinic covers.
- Planning your Istanbul treatment tripRecords, travel timing, local transport, accommodation, and follow-up after you fly home.
- Choosing a stem cell clinic in IstanbulHow we document candidacy, pricing, clinical oversight, and aftercare for international patients.
- Rules and oversight in TurkeyHow regenerative medicine is regulated in Türkiye, and the paperwork that accompanies treatment.
- Reading stem cell success ratesWhat a published percentage can and cannot tell you about your own diagnosis.
- What your treatment quote includesWhat the clinical fee covers, which items are listed separately, and what moves the total.
- What to expect during treatmentThe remote case review, your written plan, the treatment day, and follow-up once you are home.
- Longevity and healthy-ageing care in IstanbulWhat our longevity programme assesses, and how it differs from treating a diagnosed condition.
- What exosome treatment in Istanbul costsHow we structure an exosome quote, and the line items a written estimate names.
- Exosome therapy questions we are askedSourcing, dosing, regulation, and the documentation that accompanies a proposed treatment.
- Medical travel to Turkey: patient guideHow remote record reviews, clinic scheduling, and travel logistics fit together.
- Comparing treatment abroad: Turkey vs MexicoQuestions to ask when comparing clinics, cell documentation, and oversight across countries.
Condition guides
Treatments & the science
- Stem Cell Therapy Overview
- Introduction to Stem Cell Therapy
- Umbilical Cord Stem Cells (UC-MSCs)
- Mesenchymal Stem Cell (MSC) Therapy
- How Stem Cells Work
- Safety & Treatment Process
- Exosome Therapy Overview
- How Exosomes Work
- Stem Cells vs Exosomes
- Intravenous (IV) Stem Cell Therapy
- Intrathecal Stem Cell Therapy
- Longevity Program
- See all treatments →
International patient support
Talk to our medical team about Umbilical Cord MSC Therapy.
Send your diagnosis, reports, imaging and current medication. Our medical team explains which options may fit your case, what the treatment involves, and what your stay in Istanbul would look like.
Nothing needs to be booked to begin. Our patient coordination team plans your visit to Istanbul once your treatment plan is agreed.

